STOCK TITAN
  1. Home
  2. CELG

Celgene (CELG) Stock Price, News & Analysis

CELG NASDAQ
Published by Stock Titan Data refreshed

What Changed

Company Description

This page collects what Stock Titan holds for CELG, including price data and SEC filings.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All

No recent news available for CELG.

SEC Filings

View All

[4] Bristol Myers Squibb (BMY) withholds 2,332 shares for taxes as Cari Gallman's stock award vests.

[4] A Bristol Myers Squibb (BMY) director acquires 560.897 deferred stock units.

[4] Director Samuels acquires 821.314 deferred share units in Bristol Myers Squibb (BMY).

[4] After acquiring 620.994 deferred stock units, Rice holds 42,084.867 at Bristol Myers Squibb (BMY).

[4] Director Michael R. McMullen acquires 560.897 deferred stock units at Bristol Myers Squibb (BMY).

[4] Bristol Myers Squibb (BMY) director Arduini now holds 74,077 deferred stock units.

[4] Bristol Myers (NYSE: BMY) insider unloads 6,249 shares

[144] Planned $403K Bristol Myers (NYSE: BMY) stock sale disclosed

[4] Tax withholding trims Bristol Myers (NYSE: BMY) exec's 1,236-share RSU vesting

[4] Bristol Myers (NYSE: BMY) SVP sale not under 10b5-1 plan

Celgene has filed 10 recent SEC filings, including 9 Form 4, 1 Form 144. The most recent filing was submitted on October 5, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CELG SEC filings →